Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Boill Healthcare Holdings Limited ( (HK:1246) ) has provided an announcement.
Boill Healthcare Holdings has disclosed that Hong Kong’s Listing Committee has decided to cancel the listing of its shares after the company failed to meet all resumption guidance requirements and did not resume trading by the prescribed deadline. The exchange cited deficiencies including failure to demonstrate compliance with Rule 13.24 on sufficient operations and assets, concerns over management integrity, shortcomings in internal controls, and incomplete disclosure of material information.
The company has exercised its right to seek a review of the delisting decision by the Listing Review Committee and formally lodged a review request, while cautioning shareholders that the outcome remains uncertain. Trading in Boill Healthcare’s shares, suspended since July 2024, will stay halted until the exchange is satisfied that all resumption conditions are fulfilled, leaving investors facing prolonged illiquidity and heightened uncertainty over the stock’s future listing status.
More about Boill Healthcare Holdings Limited
Boill Healthcare Holdings Limited, incorporated in the Cayman Islands and listed in Hong Kong, operates through a group structure referred to as the Group. The company is engaged in the healthcare sector, with its shares traded on the Main Board of the Stock Exchange of Hong Kong under stock code 1246, and it has been subject to resumption guidance following an extended trading suspension.
Technical Sentiment Signal: Sell
Current Market Cap: HK$28.52M
For a thorough assessment of 1246 stock, go to TipRanks’ Stock Analysis page.